Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
Kowdley et al NEJM 2023. Nov 13. doi: 10.1056/NEJMoa2306185 Πατώντας ΕΔΩ μπορείτε να δείτε το άρθρο
Λεπτομέρειες
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase
Huang D, Tran A, Yeh ML, Yasuda S, Tsai PC, Pei-Chien H, et al. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase. Hepatology 78(5):p 1558-1568, November 2023. | DOI: 10.1097/HEP.0000000000000459 Πατώντας ΕΔΩ μπορείτε να δείτε το άρθρο
Λεπτομέρειες
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Shukui Q., Minshan C., Ann-Lii C. et al. for the IMbrave050 investigators The Lancet, October 2023 (published online first) doi: (https://doi.org/10.1016/S0140-6736(23)01796-8) Δείτε ΕΔΩ το άρθρο.
Λεπτομέρειες
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement
Transplant International 36:11729. DOI: 10.3389/ti.2023.11729 https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11729/full Δείτε ΕΔΩ το άρθρο.
Λεπτομέρειες
Τυχαιοποιημένη, ελεγχόμενη δοκιμή του αναλόγου FGF21 Pegozafermin στη NASH
Rohit Loomba, M.D., M.H.Sc., Arun J. Sanyal, M.D., Kris V. Kowdley, M.D., et al N Engl J Med 2023; 389:998-1008 DOI: 10.1056/NEJMoa2304286 Δείτε ΕΔΩ το άρθρο.
Λεπτομέρειες
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis
Elton Dajti, Federico Ravaioli, Romanas Zykus, et al, on behalf of the Spleen Stiffness—IPD-MA Study Group* Lancet Gastroenterol Hepatolοgy 2023; 8: 816–28 https://doi.org/10.1016/S2468-1253(23)00150-4 Δείτε ΕΔΩ το άρθρο.
Λεπτομέρειες
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection
Pelizzaro F., Trevisani F., Simeon V. et al. for the Italian Liver Cancer (ITA.LI.CA.) group Liver International 2023, Sep 27. doi: https://doi.org/10.1111/liv.15719 Δείτε ΕΔΩ την περίληψη του άρθρου.
Λεπτομέρειες
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
Chun HS, Papatheodoridis GV, Lee M, Lee HA, Kim YH, Kim SH, Oh YS, Park SJ, Kim J, Lee HA, Kim HY, Kim TH, Yoon EL, Jun DW, Ahn SH, Sypsa V, Yurdaydin C, Lampertico P, Calleja JL, Janssen HL, Dalekos GN, Goulis J, Berg T, Buti M, Kim SU, Kim YJ. Journal of Hepatology…
Λεπτομέρειες
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Sean Wharton, M.D., Thomas Blevins, M.D., Lisa Connery, M.D., et al for the GZGI Investigators* N Engl J Med 2023; 389:877-888DOI: 10.1056/NEJMoa2302392 Δείτε ΕΔΩ την περίληψη του άρθρου
Λεπτομέρειες
Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures
Sean Wharton, M.D., Thomas Blevins, M.D., Lisa Connery, M.D., et al for the GZGI Investigators* N Engl J Med 2023; 389:877-888DOI: 10.1056/NEJMoa2302392 Δείτε ΕΔΩ την περίληψη του άρθρου
Λεπτομέρειες